Impact of the EXOMIND (BTL-699-2) on the Brain Reward Pathway

NANot yet recruitingINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

July 22, 2025

Primary Completion Date

December 1, 2025

Study Completion Date

September 1, 2026

Conditions
Binge Eating BehaviourBinge Eating/Loss of Control EatingFood Craving
Interventions
DEVICE

Treatment with BTL-699-2 device

The treatment schedule with BTL-699-2 device will consist of six 24.5-minute treatments spaced 3-7 days apart. The therapy parameters will be adjusted according to patient feedback, but should never exceed 70% of the individual's MT in the active group.

DEVICE

Treatment with BTL-699-2 device with intensity below therapeutic threshold

The treatment schedule with BTL-699-2 device will consist of six 24.5-minute treatments spaced 3-7 days apart. The intensity of the energy will be set below the therapeutic threshold.

Trial Locations (1)

25067

National Institute of Mental Health in Czechia, Klecany

All Listed Sponsors
lead

BTL Industries Ltd.

INDUSTRY